Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-660,309
Closed -$19M 354
2021
Q4
$19M Buy
660,309
+4,832
+0.7% +$157K 0.11% 141
2021
Q3
$26.3M Sell
655,477
-72
-0% -$3.22K 0.14% 138
2021
Q2
$28.5M Buy
655,549
+18,196
+3% +$752K 0.14% 141
2021
Q1
$24M Sell
637,353
-12,148
-2% -$519K 0.13% 143
2020
Q4
$25.8M Sell
649,501
-8,381
-1% -$342K 0.13% 139
2020
Q3
$27.4M Buy
657,882
+16,256
+3% +$743K 0.17% 121
2020
Q2
$27M Buy
641,626
+219,522
+52% +$6.74M 0.21% 108
2020
Q1
$8.14M Sell
422,104
-177,827
-30% -$6.01M 0.1% 127
2019
Q4
$23.1M Buy
+599,931
New +$22.5M 0.24% 96

Other funds holding XP

Gilder Gagnon Howe & Co's XP Position: Q1 2022 in Review

Gilder Gagnon Howe & Co sold out of XP (XP) in Q1 2022, closing a stake of 660,309 shares — an estimated $19M sold.

Gilder Gagnon Howe & Co first reported a position in XP in Q4 2019 and held it in 9 quarters. The position peaked at $28.5M in Q2 2021. 238 funds tracked by Wall St. Rank hold XP as of Q1 2022.

  • Gilder Gagnon Howe & Co reported no remaining XP position as of Q1 2022 after selling out during the quarter.
  • Gilder Gagnon Howe & Co sold 660,309 XP shares in Q1 2022, an estimated $19M.
  • Gilder Gagnon Howe & Co first reported a position in XP in Q4 2019 and held it in 9 quarters.
  • Gilder Gagnon Howe & Co's XP position peaked at $28.5M in Q2 2021.
  • 238 funds tracked by Wall St. Rank held XP as of Q1 2022.

Based on Gilder Gagnon Howe & Co's 13F filing for Q1 2022, filed 16 May 2022.